GlassScriptPhysician profile
Amy Lewis
NPI 1134586290
$5,154.37
in general payments reported to CMS, 2019-2025
38 companies · $977 in 2025
The $977 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $947 · 2022: $952 · 2023: $1,087 · 2024: $1,192 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,255.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,028.44 | 2021-2025 | |
| Glaxosmithkline, LLC. | $628.36 | 2021-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $542.45 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $362.10 | 2021-2025 | Otezla, Repatha, Otezla |
| Lilly USA, LLC | $297.31 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Pfizer INC. | $288.23 | 2021-2025 | |
| Astellas Pharma US INC | $248.30 | 2023-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $239.37 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $229.88 | 2021-2025 | |
| Abbott Laboratories | $164.18 | 2025 | Jot Dx, Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $157.09 | 2022-2024 | Ajovy, Austedo Xr, Austedo |
| Shield Therapeutics INC | $104.60 | 2024 | |
| Merck Sharp & Dohme LLC | $101.79 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Corcept Therapeutics | $88.18 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $77.60 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.51 | 2022-2024 | Synjardy, Jardiance, Tradjenta |
| Exact Sciences Corporation | $49.21 | 2024-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $41.69 | 2023-2025 | Vyepti, Rexulti |
| Otsuka America Pharmaceutical, INC. | $39.02 | 2022-2024 | Rexulti |
| Biogen, INC. | $36.47 | 2025 | Vumerity, Tysabri |
| Bayer Healthcare Pharmaceuticals INC. | $34.55 | 2022-2025 | |
| Daiichi Sankyo INC. | $33.03 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.33 | 2021-2024 | Xifaxan |
| Amneal Pharmaceuticals LLC | $24.59 | 2025 | Brekiya |
| Vanda Pharmaceuticals INC. | $24.32 | 2024 | Fanapt, Hetlioz |
| Harmony Biosciences LLC | $24.07 | 2023 | Wakix |
| Abiomed | $21.58 | 2025 | |
| Eisai INC. | $21.03 | 2021 | |
| Nevro Corp. | $19.69 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.37 | 2022 | |
| Tris Pharma INC | $19.26 | 2023 | Dyanavel Xr |
| Mayne Pharma Commercial LLC | $17.96 | 2025 | |
| Amarin Pharma, INC. | $17.15 | 2022 | |
| Inogen, INC. | $16.81 | 2024 | |
| Tonix Medicines, INC. | $15.82 | 2025 | Zembrace Symtouch |
| Radius Health, INC. | $15.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.47 | 2024 | Trintellix |
| Phathom Pharmaceuticals, INC. | $3.89 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.